My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: Alliance Management  alliances  collaboration  partnering  alliance managers  alliance  partners  alliance manager  partnerships  ecosystem  partner  The Rhythm of Business  Strategic Alliance Magazine  Jan Twombly  Eli Lilly and Company  governance  IoT  partnership  biopharma  NetApp  Vantage Partners  2015 ASAP Global Alliance Summit  ASAP BioPharma Conference  Cisco  Healthcare  strategy  innovation  collaborations  C-Suite  Digital Transformation 

Change as a Constant: A Timely Session Planned for the ASAP BioPharma Conference

Posted By Geena B. Richards and Cynthia B. Hanson, Tuesday, October 23, 2018

Managing cycles of change is a session theme certain to unpack a profusion of thought-provoking ideas at the 2018 ASAP BioPharma Conference “Creating Valuable and Innovative Partnerships by Driving the Alliance Mindset,” September 24-26 at the Hyatt Regency Boston in Boston, Massachusetts USA. When change is afoot, alliance managers must learn how to quickly shift, dance, adapt, and evolve to keep pace in today’s meteoric biopharma partnering climate. How do alliance managers maintain an alliance mindset while negotiating fast-paced strategic changes, organizational shifts, and the introduction of new leadership? In a buzz of constant change, how do teams continue to listen to future needs? These are just a few of the challenges that will be addressed in the session “Leading Alliance Management amidst Shifting Corporate Strategy,” moderated by Andy Eibling, CSAP, senior partner at Forty86 Consulting Group. He will bring four panelists together to tackle this topic along with audience participation: Nick Dunscombe, vice president of business & commercial development at Astellas Pharma Europe; Mojgan Hossein-Nia, vice president, head of the R&D partnership office, Takeda; Steve Twait, CSAP, vice president alliance and integration management at AstraZeneca; Lucinda Warren, vice president business development, neuroscience, Johnson & Johnson Innovation/Janssen Business Development. Eibling recently provided a brief preview of some of the focal points the panelists plan to discuss.

What were some of the themes of this session?
Three of the four panelists have undergone significant changes in their careers. The fourth went through big organizational shifts not too long ago and has had multiple jobs within the organization. As the moderator, I will let them paint their own portrait and tell their own story and then go into targeted questions. We will discuss a lot of the problems associated with transitioning and how the panelists have solved them. We plan to stay within the alliance mindset and talk about how to ensure that the right mindset is in place as your alliance goes through strategic changes or as you are introduced into a new organization. Those changes could be an organizational shift from centralized to decentralized or a move to organize by therapeutic area to business unit. Changes to alliances, such as asset divestitures, will be covered. We will talk a little bit about tools and technology and how they are being used to learn and share expertise. As we talk about changes in strategies, we will get into metrics and how you can leverage them to ensure that you stay true to the alliances and their objectives. What metrics are companies incorporating to measure not just alliance health, but collaboration value? Another topic is how to design a Center of Excellence. This group has lots of expertise and different types of experiences.

What are some of the biggest challenges pharma alliance managers face today when dealing with corporate restructuring, both internally and externally?
That’s one of the themes we will address. As your organization shifts, by business unit or a move to a decentralized structure, what impact does that have? How does that change impact how your team performs? Constant change is the norm today as corporations strive to deliver much-needed innovative therapies to patients, increase revenues, and provide shareholder value. All the change we are talking about could be interpreted as ecosystem change for lasting solutions. The answers need to be flexible, not only relating to what you are going through now but predicting the next change as the pendulum swings. When the bowl of asset divestment wanes, what’s next? And do you have the right skills for the coming changes? What are the trends in non-traditional partnerships? Is the alliance language the same in the collaboration lifecycle?

What about adapting to changes in company culture? Will you be discussing these types of changes as well?
We are going to make sure to incorporate questions from the audience, and I wouldn’t be surprised if that comes up as a question. Nick Dunscombe, one of the panelists, just moved from a British to a Japanese company with a strong presence in the United States. He moved from alliance management at AstraZeneca to Astellas. Corporate culture might be something he could address. How do you apply what you know, what you learn, and how you shift? He will discuss best practices and the differences in the companies. Also, how do you adapt and how do you do it differently? What things worked in the past?

For more discussion of critical biopharma partnering topics and conference coverage, check out the Q2 and Q3 2018 issues of Strategic Alliance Magazine and the August 2018 issue of eSAM Plus.

Tags:  2018 ASAP BioPharma Conference  alliance manager  alliance mindset  Andy Eibling  Astellas  AstraZeneca  corporate culture  corporate restructuring  Johnson & Johnson Innovation  Lucinda Warren  Mojgan Hossein-Nia  Nick Dunscombe  non-traditional partnerships  Steve Twait  strategic challenges  Takeda 

Share |
PermalinkComments (0)
 

ASAP Alliance for Corporate Social Responsibility Award Presented to The Synergist-Sanofi for Innovative ‘Break Dengue’ Initiative

Posted By Noel B. Richards and Cynthia B. Hanson, Wednesday, March 29, 2017

The Alliance for Corporate Social Responsibility award is an indispensable leg on the table of four ASAP Alliance Excellence Awards presented to finalists each year at the annual Global Alliance Summit. Submissions for the Alliance for Corporate Social Responsibility award were starkly absent in 2016, but this year three outstanding finalists stepped up to the plate to vie for the honor. The winner was pharmaceutical company Sanofi and The Synergist, a Brussels-based non-profit. Sanofi was looking for new and progressive ways to educate the public about dengue fever, and the “Break Dengue” multi-partner initiative with The Synergist and several other entities was hatched in response. The award was announced at the 2017 ASAP Global Alliance Summit, “Profit, Innovation, and Value for the Partnering Enterprise,” which took place at the San Diego Marriott Mission Valley, San Diego, California.

Sanofi is well known in the pharma industry; The Synergist is a nonprofit newcomer that builds collaborations by piecing together the right people and organizations for the project. The Synergist works to “bring together the stakeholders that can make a difference. These include corporations, academics, other experts, medical professionals, patients, and NGOs,” according to its website www.thesynergist.org. Founder Nicholas Brooke was CEO of ZN, a Brussels-based digital marketing agency, when he became inspired by a TED Talk by Simon Sinek called “How Great Leaders Inspire Action” (view talk here: http://www.ted.com/talks/simon_sinek_how_great_leaders_inspire_action). Brooke had enjoyed financial success at ZN and decided to leave the company to build The Synergist with an agenda for solving social or societal issues and the motto “Partner for Greater Societal Impact.”

ZN began the Break Dengue project as a way to start building awareness for dengue fever, a neglected tropical disease. Sanofi Pasteur then seized the opportunity to join the effort and signed on to the project. This decision had a profound impact on Sanofi Pasteur’s corporate culture. Celine Schillinger, head of innovation and engagement, was one of many in her company who embraced the challenge. She told hundreds of partnering executives: “I want to change the way organizations work. I want to make business more humane and more relevant to what employees, customers, and stakeholders at large want today.” (See link on Sanofi’s goals at http://www.strategic-alliances.org/blogpost/1143942/270931/Changing-Corporate-Culture-To-Create-Social-Impact-A-Plenary-by-Celine-Schillinger .)

The Break Dengue multi-party alliance is unique because no one group or stakeholder promotes the answer. Instead, the alliance brings in different groups with diverse and unique strengths. For example, the Malaria Consortium joined to provide expertise in combating mosquito breeding grounds. Reflecting on the collaborative created for Break Dengue, Celine Schillinger remarked: “If we can overcome [the competitive mindset], we can fulfill something that’s bigger than ourselves and bigger than our organization's goals.”

Several innovative processes turned the project into a success. The collaboration has been in place for two years working to raise awareness and reduce incidence. It has become the No. 1 source and presence for public information about dengue fever by connecting healthcare providers, NGOs, researchers, local groups, and pharma. Break Dengue also has created an online scientific community known as “Dengue Lab.”

“This community is the greatest online platform used to collaborate and share efforts to combat dengue fever,” remarked Aaron Hoyles, program manager at The Synergist, during an interview shortly after the awards ceremony. For example, as part of its collaborative efforts, “Break Dengue was able to raise awareness about dengue fever during the 2014 World Cup through a campaign called ‘Red Card to Dengue.’ The campaign reached over one million followers, receiving over 81,000 views on its YouTube video.”

An online dengue tracking tool was then created to allow endemic areas to interact with a chat tool that helps them learn if they, or someone they know, has been exposed. The tool allows a map to pop up that people can view to determine the status of dengue fever in their area, along with information on sources of treatment or prevention. The Break Dengue website can be viewed at this link: https://www.breakdengue.org/

Tags:  “Break Dengue”  Celine Schillinger  collaboration  Corporate Culture  dengue fever  multi-partner initiative  Nicholas Brooke  Sanofi  Simon Sinek  stakeholders  TED Talk  The Synergist 

Share |
PermalinkComments (0)
 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630